The dangerous liaison between iNKT cells and dendritic cells: Does it prevent or promote autoimmune diseases?

References

• Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D. CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J Exp Med. 1995; 182:993–1004.
   PubMed Web of Science ®Google Scholar
• Park SH, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med. 2001; 193:893–904.
   Google Scholar
• Godfrey DI, Kronenberg M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J Clin Invest. 2004; 114:1379–1388.
   PubMed Web of Science ®Google Scholar
• Hammond KJ, Pellicci DG, Poulton LD, Naidenko OV, Scalzo AA, Baxter AG, Godfrey DI. CD1d-restricted NKT cells: An interstrain comparison. J Immunol. 2001; 167:1164–1173.
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: Facts, functions and fallacies. Immunol Today. 2000; 21:573–583.
   PubMedGoogle Scholar
• Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol. 2002; 2:557–568.
   PubMed Web of Science ®Google Scholar
• Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med. 2000; 191:1895–1903.
   PubMed Web of Science ®Google Scholar
• Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 1998; 188:1521–1528.
   PubMed Web of Science ®Google Scholar
• Brigl M, Brenner MB. CD1: Antigen presentation and T cell function. Annu Rev Immunol. 2004; 22:817–890.
   PubMed Web of Science ®Google Scholar
• Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity. 2000; 12:211–221.
   PubMed Web of Science ®Google Scholar
• Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 1997; 278:1626–1629.
   PubMed Web of Science ®Google Scholar
• Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res. 1995; 7:529–534.
   PubMed Web of Science ®Google Scholar
• Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol. 2005; 35:1692–1701.
   PubMed Web of Science ®Google Scholar
• Mattner J, Debord KL, Ismail N, Goff RD, Cantu CIII, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 2005; 434:525–529.
   PubMed Web of Science ®Google Scholar
• Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, Behar SM, Beutler B, Wilson IA, Tsuji M, Sellati TJ, Wong CH, Kronenberg M. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol. 2006; 7:978–986.
   PubMed Web of Science ®Google Scholar
• Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 2005; 434:520–525.
   PubMed Web of Science ®Google Scholar
• Amprey JL, Im JS, Turco SJ, Murray HW, Illarionov PA, Besra GS, Porcelli SA, Spath GF. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med. 2004; 200:895–904.
   PubMed Web of Science ®Google Scholar
• Zajonc DM, Cantu CIII, Mattner J, Zhou D, Savage PB, Bendelac A, Wilson IA, Teyton L. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol. 2005; 6:810–818.
   PubMed Web of Science ®Google Scholar
• Gadola SD, Silk JD, Jeans A, Illarionov PA, Salio M, Besra GS, Dwek R, Butters TD, Platt FM, Cerundolo V. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med. 2006; 203:2293–2303.
   Google Scholar
• D'Andrea A, Goux D, De Lalla C, Koezuka Y, Montagna D, Moretta A, Dellabona P, Casorati G, Abrignani S. Neonatal invariant Va24+ NKT lymphocytes are activated memory cells. Eur J Immunol. 2000; 30:1544–1550.
   PubMedGoogle Scholar
• Chiu YH, Park SH, Benlagha K, Forestier C, Jayawardena-Wolf J, Savage PB, Teyton L, Bendelac A. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol. 2002; 3:55–60.
   PubMed Web of Science ®Google Scholar
• Streilein JW. Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003; 3:879–889.
   PubMed Web of Science ®Google Scholar
• Streilein JW. New thoughts on the immunology of corneal transplantation. Eye (Lond). 2003; 17:943–948.
   PubMedGoogle Scholar
• Streilein JW. Ocular immune privilege: The eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003; 74:179–185.
   PubMed Web of Science ®Google Scholar
• Sonoda KH, Faunce DE, Taniguchi M, Exley M, Balk S, Stein-Streilein J. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol. 2001; 166:42–50.
   PubMed Web of Science ®Google Scholar
• Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med. 1999; 190:1215–1226.
   PubMed Web of Science ®Google Scholar
• Faunce DE, Sonoda KH, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol. 2001; 166:313–321.
   PubMed Web of Science ®Google Scholar
• Faunce DE, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol. 2002; 169:31–38.
   PubMed Web of Science ®Google Scholar
• Niederkorn JY, Streilein JW. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J Immunol. 1983; 131:2670–2674.
   PubMed Web of Science ®Google Scholar
• Keino H, Takeuchi M, Kezuka T, Hattori T, Usui M, Taguchi O, Streilein JW, Stein-Streilein J. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Invest Ophthalmol Vis Sci. 2006; 47:1047–1055.
   Google Scholar
• Sonoda KH, Nakamura T, Young HA, Hart D, Carmeliet P, Stein-Streilein J. NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J Immunol. 2007; 179:2215–2222.
   Google Scholar
• Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997; 389:737–742.
   PubMed Web of Science ®Google Scholar
• Ikehara Y, Yasunami Y, Kodama S, Maki T, Nakano M, Nakayama T, Taniguchi M, Ikeda S. CD4+ Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest. 2000; 105:1761–1767.
   PubMed Web of Science ®Google Scholar
• Sablinski T, Hancock WW, Tilney NL, Kupiec-Weglinski JW. CD4 monoclonal antibodies in organ transplantation–a review of progress. Transplantation. 1991; 52:579–589.
   PubMed Web of Science ®Google Scholar
• Seino KI, Fukao K, Muramoto K, Yanagisawa K, Takada Y, Kakuta S, Iwakura Y, Van Kaer L, Takeda K, Nakayama T, Taniguchi M, Bashuda H, Yagita H, Okumura K. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA. 2001; 98:2577–2581.
   PubMed Web of Science ®Google Scholar
• Jie Y, Pan Z, Xu L, Chen Y, Zhang W, Wu Y, Peng H. Upregulation of CD4+ NKT cells is important for allograft survival in staphylococcal-enterotoxin-B-treated rats after high-risk corneal transplantation. Ophthalmic Res. 2007; 39:130–138.
   Google Scholar
• Sonoda KH, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol. 2002; 168:2028–2034.
   PubMed Web of Science ®Google Scholar
• Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, Voehringer D. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med. 2009; 2063:549–559.
   Google Scholar
• Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature. 2006; 441:235–238.
   PubMed Web of Science ®Google Scholar
• Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. J Immunol. 2000; 165:5304–5314.
   PubMedGoogle Scholar
• Glabinski AR, Krakowski M, Han Y, Owens T, Ransohoff RM. Chemokine expression in GKO mice (lacking interferon-γ) with experimental autoimmune encephalomyelitis. J Neurovirol. 1999; 5:95–101.
   PubMed Web of Science ®Google Scholar
• Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, Lassmann H, Herbelin A, Lehuen A, Liblau RS. Cutting edge: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol. 2002; 168:6007–6011.
   PubMed Web of Science ®Google Scholar
• Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med. 2001; 194:1789–1799.
   PubMed Web of Science ®Google Scholar
• Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001; 194:1801–1811.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells. Nature. 2001; 413:531–534.
   PubMed Web of Science ®Google Scholar
• Oki S, Tomi C, Yamamura T, Miyake S. Preferential Th2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int Immunol. 2005; 17:1619–1629.
   PubMedGoogle Scholar
• Mars LT, Gautron AS, Novak J, Beaudoin L, Diana J, Liblau RS, Lehuen A. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J Immunol. 2008; 181:2321–2329.
   PubMed Web of Science ®Google Scholar
• Xu W, Fazekas G, Hara H, Tabira T. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2005; 163:24–30.
   PubMed Web of Science ®Google Scholar
• Furlan R, Bergami A, Cantarella D, Brambilla E, Taniguchi M, Dellabona P, Casorati G, Martino G. Activation of invariant NKT cells by αGalCer administration protects mice from MOG35-55-induced EAE: Critical roles for administration route and IFN-γ. Eur J Immunol. 2003; 33:1830–1838.
   PubMed Web of Science ®Google Scholar
• Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity?. Trends Immunol. 2002; 23:445–449.
   PubMed Web of Science ®Google Scholar
• Kojo S, Seino K, Harada M, Watarai H, Wakao H, Uchida T, Nakayama T, Taniguchi M. Induction of regulatory properties in dendritic cells by Vα14 NKT cells. J Immunol. 2005; 175:3648–3655.
   PubMed Web of Science ®Google Scholar
• Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol. 2005; 23:447–485.
   PubMed Web of Science ®Google Scholar
• Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: Role in autoimmune disease and therapeutic opportunities. Immunol Rev. 2008; 223:371–390.
   PubMed Web of Science ®Google Scholar
• Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol. 2008; 9:239–244.
   PubMed Web of Science ®Google Scholar
• Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med. 2001; 7:1057–1062.
   PubMed Web of Science ®Google Scholar
• Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001; 7:1052–1056.
   PubMed Web of Science ®Google Scholar
• Falcone M, Facciotti F, Ghidoli N, Monti P, Olivieri S, Zaccagnino L, Bonifacio E, Casorati G, Sanvito F, Sarvetnick N. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immunol. 2004; 172:5908–5916.
   PubMed Web of Science ®Google Scholar
• Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach JF, Monteiro RC. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med. 1998; 188:1831–1839.
   PubMed Web of Science ®Google Scholar
• Wilson SB, Kent SC, Horton HF, Hill AA, Bollyky PL, Hafler DA, Strominger JL, Byrne MC. Multiple differences in gene expression in regulatory Vα24JαQT cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA. 2000; 97:7411–7416.
   PubMed Web of Science ®Google Scholar
• Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA. Extreme Th1 bias of invariant Vα24JαQT cells in type 1 diabetes. Nature. 1998; 391:177–181.
   PubMed Web of Science ®Google Scholar
• Falcone M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N. A defect in interleukin 12-induced activation and interferon-γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J Exp Med. 1999; 190:963–972.
   PubMed Web of Science ®Google Scholar
• Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG. α/β-T cell receptor (TCR)+CD4− CD8− (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med. 1998; 187:1047–1056.
   PubMed Web of Science ®Google Scholar
• Jordan MA, Fletcher J, Baxter AG. Genetic control of NKT cell numbers. Immunol Cell Biol. 2004; 82:276–284.
   Google Scholar
• Esteban LM, Tsoutsman T, Jordan MA, Roach D, Poulton LD, Brooks A, Naidenko OV, Sidobre S, Godfrey DI, Baxter AG. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J Immunol. 2003; 171:2873–2878.
   PubMedGoogle Scholar
• Poulton LD, Smyth MJ, Hawke CG, Silveira P, Shepherd D, Naidenko OV, Godfrey DI, Baxter AG. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol. 2001; 13:887–896.
   PubMedGoogle Scholar
• Godfrey DI, Kinder SJ, Silvera P, Baxter AG. Flow cytometric study of T cell development in NOD mice reveals a deficiency in αβ TCR+CDR− CD8− thymocytes. J Autoimmun. 1997; 10:279–285.
   PubMed Web of Science ®Google Scholar
• Baxter AG, Kinder SJ, Hammond KJ, Scollay R, Godfrey DI. Association between αβ TCR+CD4− CD8− T-cell deficiency and IDDM in NOD/Lt mice. Diabetes. 1997; 46:572–582.
   PubMed Web of Science ®Google Scholar
• Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest. 2004; 114:1800–1811.
   PubMed Web of Science ®Google Scholar
• Mi QS, Ly D, Zucker P, McGarry M, Delovitch TL. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes. 2004; 53:1303–1310.
   PubMed Web of Science ®Google Scholar
• Ly D, Mi QS, Hussain S, Delovitch TL. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J Immunol. 2006; 177:3695–3704.
   PubMed Web of Science ®Google Scholar
• Hussain S, Wagner M, Ly D, Delovitch TL. Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes. Immunol Res. 2005; 31:177–188.
   Google Scholar
• Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol. 1994; 71:169–175.
   PubMedGoogle Scholar
• Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med. 1993; 178:87–99.
   PubMed Web of Science ®Google Scholar
• Mizuno M, Masumura M, Tomi C, Chiba A, Oki S, Yamamura T, Miyake S. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J Autoimmun. 2004; 23:293–300.
   PubMed Web of Science ®Google Scholar
• Pakala SV, Kurrer MO, Katz JD. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med. 1997; 186:299–306.
   Google Scholar
• Rocha-Campos AC, Melki R, Zhu R, Deruytter N, Damotte D, Dy M, Herbelin A, Garchon HJ. Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: Improved Vα14-NKT cell performance but failure to protect against type 1 diabetes. Diabetes. 2006; 55:1163–1170.
   PubMedGoogle Scholar
• Hultgren B, Huang X, Dybdal N, Stewart TA. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 1996; 45:812–817.
   PubMed Web of Science ®Google Scholar
• Novak J, Beaudoin L, Griseri T, Lehuen A. Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J Immunol. 2005; 174:1954–1961.
   PubMed Web of Science ®Google Scholar
• Cain JA, Smith JA, Ondr JK, Wang B, Katz JD. NKT cells and IFN-γ establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J Immunol. 2006; 176:1645–1654.
   PubMed Web of Science ®Google Scholar
• Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D, Beaudoin L, Schrike C, Von Herrath M, Lehuen A, Glaichenhaus N. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic β cells. Immunity. 2002; 16:169–181.
   PubMed Web of Science ®Google Scholar
• Beaudoin L, Laloux V, Novak J, Lucas B, Lehuen A. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells. Immunity. 2002; 17:725–736.
   PubMed Web of Science ®Google Scholar
• Novak J, Beaudoin L, Park S, Griseri T, Teyton L, Bendelac A, Lehuen A. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J Immunol. 2007; 178:1332–1340.
   PubMed Web of Science ®Google Scholar
• Chen YG, Choisy-Rossi CM, Holl TM, Chapman HD, Besra GS, Porcelli SA, Shaffer DJ, Roopenian D, Wilson SB, Serreze DV. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol. 2005; 174:1196–2004.
   PubMed Web of Science ®Google Scholar
• Luft T, Luetjens P, Hochrein H, Toy T, Masterman KA, Rizkalla M, Maliszewski C, Shortman K, Cebon J, Maraskovsky E. IFN-α enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol. 2002; 14:367–380.
   PubMed Web of Science ®Google Scholar
• Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, Lejon K, Fathman CG, Mueller SN, Shortman K, Carbone FR, Heath WR. The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med. 2002; 196:1099–2004.
   PubMed Web of Science ®Google Scholar
• Naumov YN, Bahjat KS, Gausling R, Abraham R, Exley MA, Koezuka Y, Balk SB, Strominger JL, Clare-Salzer M, Wilson SB. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA. 2001; 98:13838–13843.
   PubMed Web of Science ®Google Scholar
• Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes. 1999; 48:2300–2308.
   PubMed Web of Science ®Google Scholar
• Morel PA, Vasquez AC, Feili-Hariri M. Immunobiology of DC in NOD mice. J Leukoc Biol. 1999; 66:276–280.
   Google Scholar
• Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology. 2001; 103:407–416.
   PubMed Web of Science ®Google Scholar
• Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980; 283:666–668.
   PubMed Web of Science ®Google Scholar
• Kaieda S, Tomi C, Oki S, Yamamura T, Miyake S. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Arthritis Rheum. 2007; 56:1836–1845.
   PubMedGoogle Scholar
• Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide. Arthritis Rheum. 2004; 50:305–313.
   PubMed Web of Science ®Google Scholar
• Miellot A, Zhu R, Diem S, Boissier MC, Herbelin A, Bessis N. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway. Eur J Immunol. 2005; 35:3704–3713.
   Google Scholar
• Liu R, La Cava A, Bai XF, Jee Y, Price M, Campagnolo DI, Christadoss P, Vollmer TL, Van Kaer L, Shi FD. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. J Immunol. 2005; 175:7898–7904.
   PubMed Web of Science ®Google Scholar
• Yang JQ, Saxena V, Xu H, Van Kaer L, Wang CR, Singh RR. Repeated α-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J Immunol. 2003; 171:4439–4446.
   PubMed Web of Science ®Google Scholar
• Zeng D, Liu Y, Sidobre S, Kronenberg M, Strober S. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest. 2003; 112:1211–1222.
   PubMed Web of Science ®Google Scholar
• Bach JF. Immunotherapy of type 1 diabetes: Lessons for other autoimmune diseases. Arthritis Res. 2002; 4:S3–S15.
   Google Scholar
• Falcone M, Bloom BR. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med. 1997; 185:901–907.
   PubMed Web of Science ®Google Scholar
• Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007; 7:610–621.
   PubMed Web of Science ®Google Scholar
• Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human V (α)24 natural killer T cells. J Exp Med. 2002; 195:637–641.
   PubMed Web of Science ®Google Scholar
• Chan WL, Pejnovic N, Liew TV, Lee CA, Groves R. NKT cell subsets in infection and inflammation. Immunol Lett. 2003; 85:159–163HamiltonH.
   PubMedGoogle Scholar
• Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007; 25:297–336.
   PubMed Web of Science ®Google Scholar
• Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol. 2003; 171:5140–5147.
   PubMed Web of Science ®Google Scholar
• Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, Farrand KJ, Salio M, Cerundolo V. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J Immunol. 2007; 178:2721–2729.
   Google Scholar
• Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB. CD1-dependent dendritic cell instruction. Nat Immunol. 2002; 3:1163–1168.
   PubMed Web of Science ®Google Scholar
• Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med. 2003; 198:267–279.
   PubMed Web of Science ®Google Scholar
• Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nat Immunol. 2002; 3:867–874.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, Kronenberg M, Nakayama T, Taniguchi M, Koezuka Y, Tsuji M. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med. 2002; 195:617–624.
   PubMed Web of Science ®Google Scholar
• Kim S, Lalani S, Parekh VV, Vincent TL, Wu L, Van Kaer L. Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. J Clin Invest. 2008; 118:2301–2315.
   PubMed Web of Science ®Google Scholar
• Hazlett LD, Li Q, Liu J, McClellan S, Du W, Barrett RP. NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice. J Immunol. 2007; 179:1138–1146.
   PubMedGoogle Scholar
• Pal E, Tabira T, Kawano T, Taniguchi M, Miyake S, Yamamura T. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J Immunol. 2001; 166:662–668.
   PubMed Web of Science ®Google Scholar